• 1
    Lawrence D., Mitrou F., Zubrick S. Global research neglect of population-based approaches to smoking cessation: time for a more rigorous science of population health interventions. Addiction 2011; 106: 154954.
  • 2
    Vandenbroucke J. P. Observational research, randomised trials, and two views of medical science. PLoS Med 2008; 5: e67.
  • 3
    Vandenbroucke J. P., Psaty B. M. Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects. JAMA 2008; 300: 24179.
  • 4
    Institute of Medicine Committee on the Assessment of the U.S. Drug Safety System, BaciuA., StrattonK. R., BurkeS. P., editors. The Future of Drug Safety: Promoting and Protecting the Health of the Public. Washington, DC: National Academies Press; 2007.
  • 5
    Murnane R. J., Willett J. B. Methods Matter: Improving Causal Inference in Educational and Social Science Research. Oxford: Oxford University Press; 2011.
  • 6
    Shadish W. R., Cook T. D., Campbell D. T. Experimental and Quasi-Experimental Designs for Generalized Causal Inference. Boston: Houghton-Mifflin; 2002.
  • 7
    Cobiac L., Vos T., Doran C., Wallace A. Cost-effectiveness of interventions to prevent alcohol-related disease and injury in Australia. Addiction 2009; 104: 164655.
  • 8
    Voas R. B., Tippetts A. S., Fell J. C. Assessing the effectiveness of minimum legal drinking age and zero tolerance laws in the United States. Accid Anal Prev 2003; 35: 57987.
  • 9
    Fell J. C., Fisher D. A., Voas R. B., Blackman K., Tippetts A. S. The relationship of underage drinking laws to reductions in drinking drivers in fatal crashes in the United States. Accid Anal Prev 2008; 40: 143040.